281 results on '"Weiss KH"'
Search Results
2. Long-term survival after liver transplantation for autoimmune hepatitis - results from the European Liver Transplant Registry
3. HER2 amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
4. Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis
5. An umbrella concept for patients with advanced intrahepatic cholangiocarcinoma
6. Hepatitis-E-Seroprävalenz, Fälle und Therapie im Kontext der Lebertransplantation
7. Proteomanalyse von extrazellulären Vesikel aus der Galle identifiziert erkrankungs- und tumorspezifischer Proteine bei Patienten mit Primär sklerosierender Cholangitis und Cholangiozellulärem Karzinom
8. RSPO2 gene rearrangement – a new cancer driver in the liver
9. Pharmacological treatment of hepatocellular cancer with cavoatrial tumor thrombus – case series and literature review
10. Variants in TM6SF2, PNPLA3 and PCSK7 are risk factors for the development of cirrhosis in people with genetic haemochromatosis
11. Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are markers for biliary damage and predict graft survival
12. Obeticholic acid for the treatment of primary biliary cholangitis – first data from a real world cohort
13. The rs626283 Variant in the MBOAT7 Gene is Associated with reduced survival in primary biliary cholangitis
14. Evaluation of serological markers of extracellular matrix remodeling in primary sclerosing cholangitis
15. An alternative model for prediction of transplant-free survival in patients with implantation of transjugular intrahepatic portosystemic shunt (TIPS): The Freiburg risk score
16. Carriage of HSD17B13 rs72613567TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis
17. Konzentration extrazellulärer Vesikel (EV) aus der Galle unterscheidet dominante Stenosen bei Primär sklerosierender Cholangitis (PSC) von malignen biliären Stenosen
18. Individualisierte Medizin mittels serieller CA19 – 9 Bestimmungen zur Tumorfrüherkennung bei Patienten mit Primär Sklerosierender Cholangitis
19. Steatose der Leber beschleunigt die Manifestation des M. Wilson im Tiermodell durch synergistische mitochondriale Schädigung
20. Erweiterte Spenderkriterien in Lebertransplantation – Aufforderung zur Vorsicht
21. Polymorphe Varianten im PNPLA3- und TM6SF2-Gen sind mit dem Hepatozellulären Karzinom bei alkoholischer Leberzirrhose assoziiert
22. In PSC with dominant bile duct stenosis, multi-resistant bacteriobilia is associated with reduced survival
23. TM6SF2 rs58542926 und PCSK7 rs236918 sind genetische Risikoloci einer Leberzirrhose bei hereditärer Hämochromatose
24. High SVR12 rates with combination of NS5A- and NS5B- inhibitors for 24 weeks in liver transplanted patients
25. Biliäre Infektionen/Kolonisationen nach Lebertransplantation: Häufigkeit, Risikofaktoren und Abhängigkeit von der biliären Intervention
26. Endoscopic treatment of biliary strictures after orthotopic liver transplantation: balloon dilatation versus stent placement. A prospective, controlled trial
27. Neurologische Assessments bei Morbus Wilson
28. Improved survival in patients with primary sclerosing cholangitis and normalization of serum cholestasis markers after biliary dilatation therapy
29. A common FUT2 variant correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis
30. Late onset of disease is associated with poor outcome in patients with primary sclerosing cholangitis
31. Comprehensive profiling and predictive molecular marker identification for hepatocellular carcinoma
32. Identification and proteomic profiling of biliary exosomes
33. Cardiac volume overload after long-term follow-up in TIPS patients
34. Hand-foot-syndrome is associated with improved survival in patients treated with sorafenib for hepatocellular carcinoma
35. Erhöhte Rivaroxaban-Spiegel unter Cyclosporin A-basierter Immunsuppression nach Lebertransplantation im Vergleich zu einer Tacrolimus-basierten Immunsuppression
36. Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary Candidiasis
37. Pfortaderthrombosen bei Patienten mit fortgeschrittener Leberzirrhose
38. Erste Erfahrungen mit der superselektiven TANDEM® TACE in Heidelberg
39. In PSC patients the influence of cholestasis and cholangitis on CA19 – 9 serum levels depends on FUT2/3 genotype
40. Reduction of alkaline phosphatase levels improves survival in PSC patients independent of dominant stenosis
41. PNPLA3 and end-stage liver disease - destigmatizing alcoholic cirrhosis?
42. Disease specific alterations of the bile-duct derived biliary proteome in primary sclerosing cholangitis
43. FUT2 genotype is a risk factor for biliary candida infections and dominant stenosis in primary sclerosing cholangitis
44. Verbesserung der Dysfunktion der primären Hämostase nach erfolgreicher Lebertransplantation: Eine Analyse der in-vitro Blutungszeit mittels des Platelet Function Analyzer (PFA-100)
45. Elevated levels of von Willebrand factor are associated with maintained normal primary haemostasis in thrombocytopenic patients with liver cirrhosis
46. Hepatobiliary malignancies in Wilson disease
47. Health-related quality of life in Wilson Disease
48. Schwangerschaft bei Morbus Wilson: Outcome und Monitoring
49. FUT2 and FUT3 depending cut-off values in PSC-patients increase diagnostic accuracy of CA19–9 for detection of biliary malignancies
50. A frequent PNPLA3 variant predicts disease course in PSC patients with dominant bile duct strictures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.